ANGPT1 and myocardial infarction: Additionally, it has been documented that RAAS AngII/AT1R axis inhibitors, apart from decreasing the levels of AngII, could prevent myocardial remodeling after MI through an increase of the ACE2/Ang 1–7/MasR axis, as shown in an animal model [43].